Shopping Cart
- Remove All
Your shopping cart is currently empty
BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $52 | In Stock | |
| 5 mg | $123 | In Stock | |
| 10 mg | $198 | In Stock | |
| 25 mg | $455 | In Stock | |
| 50 mg | $787 | In Stock | |
| 100 mg | $1,360 | In Stock | |
| 500 mg | $2,720 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $135 | In Stock |
| Description | BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer. |
| Targets&IC50 | MRCKα/β:0.0136 nM/0.0233 nM ( Ki), MRCKβ (SCC12 cells):64 nM, MRCKα/β:(ki)0.0136 nM/0.0233 nM |
| In vitro | Among over 750 human cancer cell lines tested, BDP9066 consistently exhibited anti-proliferative activity in hematologic cancer cells[1]. |
| In vivo | As an effective and selective MRCK inhibitor, BDP9066, in a two-stage chemical carcinogenesis model of mouse squamous cell carcinoma, reduced MRCKα S1003 phosphorylation and the growth of skin tumors with local treatment. |
| Molecular Weight | 348.44 |
| Formula | C20H24N6 |
| Cas No. | 2226507-04-4 |
| Smiles | C1CC[C@@]2(CCCN(C2)c2cc[nH]c3ncc(-c4ccncn4)c23)NC1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 8 mg/mL (22.96 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.